A Brief History of Utah Medical Products, Inc. (UTMD)

Foundation and Early Years

Utah Medical Products, Inc. (UTMD) was established in 1978 in Salt Lake City, Utah. The company's inception was driven by the need for specialized medical devices, particularly in the fields of urology and incontinence. The first product was a single-use urinary catheter.

Growth and Development

Throughout the 1980s and 1990s, UTMD expanded its product line to include a variety of urological and surgical products. In 1991, the company was publicly listed on the NASDAQ under the symbol UTMD. By the end of 1995, UTMD reported revenues of approximately $5.3 million.

Acquisitions and Expansion

In the early 2000s, UTMD began acquiring other medical device companies to diversify its product offerings. Notably, in 2003, UTMD acquired UroMed Corp, enhancing its capabilities in the urological market.

By 2010, UTMD had achieved revenues of approximately $11.5 million. The company continued to focus on innovation and product development, which led to significant year-over-year growth.

Recent Performance

As of 2023, UTMD reported revenues of approximately $33.2 million. The company has maintained a consistent gross profit margin of about 60% in recent years. The net income for the fiscal year 2022 was reported at approximately $6.1 million.

Product Portfolio

• Urinary Catheters
• Incontinence Products
• Urological Surgical Kits
• Access Device Products

Market Presence

UTMD operates globally, with a significant presence in North America, Europe, and Asia. The company has established partnerships with various distributors worldwide, enabling broader market access.

Financial Overview

Research and Development

UTMD allocates a significant portion of its revenue to research and development, averaging around 7% of annual revenue. The company is committed to the continuous improvement of existing products and the development of new medical technologies.

Regulatory Compliance

UTMD products comply with stringent regulatory standards, including FDA and ISO certifications. The company emphasizes quality management and continuous improvement in its processes.

Corporate Social Responsibility

UTMD is involved in various charitable initiatives, contributing to healthcare accessibility and education. The company has donated approximately $500,000 to non-profit organizations focused on health education over the past five years.

A Who Owns Utah Medical Products, Inc. (UTMD)

Company Overview

Utah Medical Products, Inc. (UTMD) is a publicly traded company focused on developing, manufacturing, and marketing medical devices. The company specializes in products for the neonatal and obstetric markets. As of the fiscal year ending December 31, 2022, UTMD reported total revenues of $17.6 million and a net income of $3.7 million.

Ownership Structure

The ownership of Utah Medical Products, Inc. is comprised of both institutional and individual shareholders. The following table outlines the major shareholders along with their respective ownership percentages as of the latest filing date, which is typically made public quarterly.

Institutional Ownership

Institutional investors represent a significant portion of UTMD's shareholders. The table below presents details of the top institutional owners and the percentage of the total shares they hold.

Insider Ownership

Insider ownership provides insight into the confidence that executives and board members have in the company. The following table lists the executive team and board members along with their ownership stakes.

Recent Stock Performance

The stock performance is a crucial indicator of market sentiment regarding UTMD. As of the close on October 31, 2023, the stock price was $20.25, with a year-to-date performance of +15%. The market capitalization stood at approximately $130 million.

Market Trend Analysis

Overall trends indicate growing interest in medical device companies, with UTMD benefiting from an expanding healthcare market. The following table demonstrates the revenue growth over the past five years.

Conclusion

Understanding who owns Utah Medical Products, Inc. provides essential insights into the company's stability and market position. This ownership analysis reflects the significant influence of institutional investors alongside a strong base of individual shareholders.

Utah Medical Products, Inc. (UTMD) Mission Statement

Corporate Overview

Utah Medical Products, Inc. (UTMD) is dedicated to developing, manufacturing, and marketing high-quality medical devices. The company primarily focuses on products for the healthcare sector, especially in the areas of obstetrics and gynecology, critical care, and urology.

Mission Statement

The mission statement of UTMD is to enhance the quality of life for patients and healthcare providers through innovative medical technologies and high-quality products. They strive to achieve this by maintaining strict adherence to regulatory standards and investing in the continued education of medical professionals.

Core Values

• Integrity: Upholding ethical standards in all business practices.
• Innovation: Commitment to research and development for product improvement.
• Quality: Ensuring the highest standards in manufacturing and product performance.
• Education: Providing ongoing training and support for users of their products.
• Customer Focus: Prioritizing the needs and feedback of healthcare providers.

Financial Performance

As of the most recent financial report, UTMD has demonstrated solid performance metrics:

Market Position

UTMD has established a prominent position in the medical device market. The global market for medical devices was valued at approximately $450 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030.

Regulatory Compliance

UTMD complies with regulations set forth by the Food and Drug Administration (FDA) and has certifications including ISO 13485:2016 for quality management systems in medical devices.

Research and Development

The company invests approximately 6% of its annual revenue into research and development, focusing on enhancing existing products and developing new innovations in the medical device field.

Social Responsibility

UTMD is committed to corporate social responsibility, which includes:

• Community Engagement: Active participation in local health initiatives and education programs.
• Sustainability: Efforts to reduce environmental impact through sustainable manufacturing practices.
• Healthcare Access: Partnerships with organizations to provide medical devices in underserved areas.

How Utah Medical Products, Inc. (UTMD) Works

Company Overview

Utah Medical Products, Inc. (UTMD) is a publicly traded company based in Midvale, Utah, specializing in the development, manufacture, and marketing of medical devices. It was founded in 1978 and focuses primarily on products for the hospital and home healthcare markets.

Product Lines

• Urodynamics Products
• Respiratory Products
• Neonate and Pediatric Products
• Dialysis Products

Market Segments

UTMD operates in both domestic and international markets, offering a range of products tailored to various healthcare needs. The geographic segmentation includes:

• North America
• Europe
• Asia
• Rest of the World

Financial Performance

In 2022, UTMD reported total revenues of approximately $39.2 million, reflecting an increase from $36.8 million in 2021. The company’s net income for 2022 was around $9.2 million, compared to $8.4 million in the previous year. Below is a summary of financial highlights:

Research and Development

UTMD is committed to innovation, investing approximately $2.5 million in research and development in 2022. This investment aims to enhance product offerings and develop new technologies that address unmet clinical needs.

Supply Chain Management

The company implements a robust supply chain strategy, emphasizing quality control and efficiency. UTMD collaborates with various suppliers for raw materials and components, focusing on maintaining high standards throughout its manufacturing processes.

Regulatory Compliance

UTMD operates under stringent regulatory oversight, ensuring that all products meet the standards set by the U.S. Food and Drug Administration (FDA) and international regulations. The company maintains ISO 13485 certification, which is critical for producing medical devices.

Market Challenges

UTMD faces several challenges in the medical device industry, including:

• Regulatory hurdles
• Market competition
• Global supply chain disruptions
• Price pressures from healthcare providers

Future Outlook

The outlook for UTMD appears positive, with projected growth driven by advancements in medical technology and an increasing demand for innovative healthcare solutions. Analysts estimate an annual growth rate of around 5-7% over the next five years.

How Utah Medical Products, Inc. (UTMD) Makes Money

Product Lines

Utah Medical Products, Inc. (UTMD) generates revenue through the design, manufacturing, and sale of medical products primarily in the areas of urology, anesthesia, and critical care.

Revenue by Product Category

The breakdown of revenue by product category for the fiscal year 2022 is as follows:

Sales Channels

UTMD utilizes multiple sales channels to reach its customers:

• Direct Sales
• Distributors
• Online Sales

Financial Performance

For the fiscal year ending December 31, 2022, Utah Medical Products, Inc. reported the following financial figures:

Market Segments

UTMD serves various market segments, including:

• Hospitals
• Outpatient Surgery Centers
• Home Healthcare

Geographic Distribution

The geographical revenue distribution for fiscal year 2022 is as follows:

Research and Development Investments

In 2022, UTMD invested approximately $2.1 million in research and development to innovate and improve existing products.

Market Trends

Key market trends impacting UTMD's revenue streams include:

• Increasing elderly population
• Growing prevalence of chronic diseases
• Advancements in medical technology

Future Projections

Analysts project a compound annual growth rate (CAGR) of approximately 5% for UTMD over the next five years, reflecting continued demand for its medical products.